Key Takeaways:
- AVNT gained 17% in 24 hours after Avantis V2 launched on Base
- V2 adds 100+ assets, $500M OI capacity, and 500+ RWA markets planned
- Token faces $0.12 resistance; losing $0.09 support would weaken bullish structure
Key Takeaways:

AVNT rose 17% to test $0.12 resistance after Avantis launched V2 on Base, adding 100+ assets and $500 million in open interest capacity.
"We have a roadmap to list 500+ RWA markets (including exotic markets never seen before onchain), with $500M+ OI over the coming weeks," Avantis said on X.
Daily trading volume jumped 1,573% to approximately $80 million. Daily transactions rose from 2,600 on Aug 8 to 9,400, a 262% increase. Weekly total reached 38,500 transactions.
The $0.12 resistance level will determine whether the upgrade-driven rally converts into sustained price appreciation. A decisive breakout could extend the recovery, while losing $0.09 would weaken the emerging bullish structure.
The V2 upgrade expanded Avantis' trading instruments while offering users leverage of up to 250x. The protocol described V2 as its largest upgrade, expanding market access, trading capacity, and user features.
On the technical side, AVNT broke above a descending trendline on Aug 7, clearing higher levels after breaking out around $0.085. The Trend Strength Index approached its upper range at 0.81, while the MACD histogram remained positive but shallow, suggesting buyers retained control although momentum lacked conviction.
The sharp rejection around $0.115-$0.12 could reflect profit-taking from traders who bought the dip. The daily market structure shifted bullish, suggesting a possible reversal or pause in the existing downtrend.
The RWA sector has become a major narrative in DeFi, with protocols like Ondo Finance tokenizing US Treasuries and attracting institutional capital. Avantis' expansion into 500+ RWA markets positions it to compete for a share of that growing market. However, network activity remained modest compared with Base's broader user base, and the event-driven demand may not sustain the rally without continued protocol growth.
This article is for informational purposes only and does not constitute investment advice.